Literature DB >> 10627521

Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus.

J Bárcena1, M Morales, B Vázquez, J A Boga, F Parra, J Lucientes, A Pagès-Manté, J M Sánchez-Vizcaíno, R Blasco, J M Torres.   

Abstract

We have developed a new strategy for immunization of wild rabbit populations against myxomatosis and rabbit hemorrhagic disease (RHD) that uses recombinant viruses based on a naturally attenuated field strain of myxoma virus (MV). The recombinant viruses expressed the RHDV major capsid protein (VP60) including a linear epitope tag from the transmissible gastroenteritis virus (TGEV) nucleoprotein. Following inoculation, the recombinant viruses induced specific antibody responses against MV, RHDV, and the TGEV tag. Immunization of wild rabbits by the subcutaneous and oral routes conferred protection against virulent RHDV and MV challenges. The recombinant viruses showed a limited horizontal transmission capacity, either by direct contact or in a flea-mediated process, promoting immunization of contact uninoculated animals.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10627521      PMCID： PMC111445          DOI： 10.1128/jvi.74.3.1114-1123.2000

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  49 in total

1.  ATTENUATION OF THE MYXOMA VIRUS AND USE OF THE LIVING ATTENUATED VIRUS AS AN IMMUNIZING AGENT FOR MYXOMATOSIS.

Authors:  J K SAITO; D G MCKERCHER; G CASTRUCCI
Journal:  J Infect Dis       Date:  1964-12       Impact factor: 5.226

Review 2.  Hepatitis of viral origin in Leporidae: introduction and aetiological hypotheses.

Authors:  J P Morisse; G Le Gall; E Boilletot
Journal:  Rev Sci Tech       Date:  1991-06       Impact factor: 1.181

3.  Transient dominant selection of recombinant vaccinia viruses.

Authors:  F G Falkner; B Moss
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

4.  Enhancement of mRNA nuclear transport by promoter elements.

Authors:  P de la Peña; M Zasloff
Journal:  Cell       Date:  1987-08-14       Impact factor: 41.582

5.  Identification and characterization of the virus causing rabbit hemorrhagic disease.

Authors:  V F Ohlinger; B Haas; G Meyers; F Weiland; H J Thiel
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

6.  Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype.

Authors:  R M Buller; G L Smith; K Cremer; A L Notkins; B Moss
Journal:  Nature       Date:  1985 Oct 31-Nov 6       Impact factor: 49.962

7.  Isolation of an attenuated myxoma virus field strain that can confer protection against myxomatosis on contacts of vaccinates.

Authors:  J Bárcena; A Pagès-Manté; R March; M Morales; M A Ramírez; J M Sánchez-Vizcaíno; J M Torres
Journal:  Arch Virol       Date:  2000       Impact factor: 2.574

8.  Purification and characterization of a calicivirus as the causative agent of a lethal hemorrhagic disease in rabbits.

Authors:  F Parra; M Prieto
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

9.  Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins.

Authors:  Y Matsuura; R D Possee; H A Overton; D H Bishop
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

10.  Sequence analysis, expression, and deletion of a vaccinia virus gene encoding a homolog of profilin, a eukaryotic actin-binding protein.

Authors:  R Blasco; N B Cole; B Moss
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103
View more
  22 in total

Review 1.  The virulence-transmission trade-off in vector-borne plant viruses: a review of (non-)existing studies.

Authors:  R Froissart; J Doumayrou; F Vuillaume; S Alizon; Y Michalakis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-06-27       Impact factor: 6.237

2.  Infection of nonhost species dendritic cells in vitro with an attenuated myxoma virus induces gene expression that predicts its efficacy as a vaccine vector.

Authors:  S Top; E Foulon; B Pignolet; M Deplanche; C Caubet; C Tasca; S Bertagnoli; G Meyer; G Foucras
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

3.  Eradicating infectious disease using weakly transmissible vaccines.

Authors:  Scott L Nuismer; Benjamin M Althouse; Ryan May; James J Bull; Sean P Stromberg; Rustom Antia
Journal:  Proc Biol Sci       Date:  2016-10-26       Impact factor: 5.349

4.  Parasites of wild rabbits (Oryctolagus cuniculus) from an urban area in Germany, in relation to worldwide results.

Authors:  Raphael Frank; Thomas Kuhn; Heinz Mehlhorn; Sonja Rueckert; Daniel Pham; Sven Klimpel
Journal:  Parasitol Res       Date:  2013-10-06       Impact factor: 2.289

5.  Genome comparison of a nonpathogenic myxoma virus field strain with its ancestor, the virulent Lausanne strain.

Authors:  Mónica Morales; Miguel A Ramírez; María J Cano; Mario Párraga; Joaquín Castilla; Luis I Pérez-Ordoyo; Juan M Torres; Juan Bárcena
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

6.  Transmissible vaccines whose dissemination rates vary through time, with applications to wildlife.

Authors:  Mark W Smithson; Andrew J Basinki; Scott L Nuismer; James J Bull
Journal:  Vaccine       Date:  2019-01-25       Impact factor: 3.641

Review 7.  Rabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): a review.

Authors:  Joana Abrantes; Wessel van der Loo; Jacques Le Pendu; Pedro J Esteves
Journal:  Vet Res       Date:  2012-02-10       Impact factor: 3.683

8.  Conformational and thermal stability improvements for the large-scale production of yeast-derived rabbit hemorrhagic disease virus-like particles as multipurpose vaccine.

Authors:  Erlinda Fernández; Jorge R Toledo; Lídice Méndez; Nemecio González; Francisco Parra; José M Martín-Alonso; Miladys Limonta; Kosara Sánchez; Ania Cabrales; Mario P Estrada; Alina Rodríguez-Mallón; Omar Farnós
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

9.  In vitro permissivity of bovine cells for wild-type and vaccinal myxoma virus strains.

Authors:  Béatrice Pignolet; Jean-Luc Duteyrat; Aude Allemandou; Jacqueline Gelfi; Gilles Foucras; Stéphane Bertagnoli
Journal:  Virol J       Date:  2007-09-27       Impact factor: 4.099

Review 10.  Self-disseminating vaccines to suppress zoonoses.

Authors:  Scott L Nuismer; James J Bull
Journal:  Nat Ecol Evol       Date:  2020-07-27       Impact factor: 19.100
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.